Streptozocin

angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33998079 Angiotensin-converting enzyme inhibitor prevents skeletal muscle fibrosis in diabetic mice. 2021 Aug 3
2 30421564 Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice. 2019 Apr 2
3 28390948 Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor (BDKRB2) polymorphism with diabetic nephropathy. 2017 Jun 1
4 26773730 Up-regulation of the Ang II/AT1 receptor may compensate for the loss of gastric antrum ICC via the PI3k/Akt signaling pathway in STZ-induced diabetic mice. 2016 Mar 5 1
5 27401876 Involvement of Spinal Angiotensin II System in Streptozotocin-Induced Diabetic Neuropathic Pain in Mice. 2016 Sep 3
6 25792018 Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro. 2015 May 26 1
7 24330074 Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy. 2014 Feb 1
8 22460064 Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism. 2012 Jun 15 2
9 17579661 ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. 2007 Sep 2
10 15326315 Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. 2004 Sep 7 1
11 10862828 Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. 2000 Jun 23 1